After intense negotiation, Novartis offered an outcome-based scheme and significantly lower NHS price, and NICE gave positive guidance under an Innovative Medicines Fund pathway
These medications have an important role to play in patients with chronic kidney disease [CKD], with or without diabetes, as well as those with cardiovascular disease, he said
Impressive findings from the STEP [24], SURMOUNT [25] and SELECT [16] trials have led to the licencing and widespread use of GLP-1/dual receptor agonists for the treatment of obesity
These side effects are transient and typically subside within a day or two following injection
Tofacitinib, a selective JAK1/JAK3 inhibitor that prevents STAT3 phosphorylation and activation, has been approved for UC treatment [95]
it works upstream, on an enzyme called nicotinamide N-methyltransferase (NNMT) that fat cells over-express when they become metabolically sluggish